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To the Editor: 
The dystrophic form of epidermolysis bullosa (DEB) can be inherited in both an autosomal 
dominant or a recessive fashion (Christiano and Uitto, 1996). The recessive form can range from a 
very severe condition (Hallopeau-Siemens DEB) to a relatively mild disease, clinically 
indistinguishable from the dominantly inherited mild form of DEB, (DDEB) (Fine et al, 2000). A 
new case of mild DEB, therefore, always presents the problem of differentiating recessively 
inherited vs. dominantly inherited DEB due either to de novo mutations or to germline mosaicism. 
The latter was previously suggested in the junctional form of epidermolysis bullosa, which 
originates from mutations in the genes encoding laminin 5 (Kivirikko et al, 1996), but has not been 
demonstrated in the case of DEB. 
Here, we report a family with one child affected by mild DEB. At birth, blistering and denuded 
areas were present together with the syndactyly of the second and third toes. By the age of 11 mo, 
blistering was significantly reduced but the blisters healed with hyperpigmented and 
hypopigmented scars and milia. Both parents and an older sibling were clinically unaffected, and 
there was no family history of consanguinity or of a blistering disorder or skin fragility. 
Screening for mutations in the COL7A1 gene in the patient using previously described techniques 
(Christiano et al, 1997) revealed a single glycine substitution in the triple helical domain of the type 
VII collagen gene (G2003R), which has previously been associated with Bart's syndrome, a form of 
DDEB (Christiano et al, 1996). This mutation, however, was not found in the peripheral blood 
DNA of the clinically unaffected parents and the sibling Figure 1. As nonpaternity based on 
parental interviews was unlikely, we concluded that the mutation was most likely a de novo event in 
the patient, and would be associated with little risk of recurrence. Nevertheless, the parents were 
appropriately counselled that the possibility of having another affected child existed, if the mutation 
existed as a germline mosaic transmitted from either parent – a possibility that was considered 
remote. 
Shortly after completing the mutation analysis, the mother became pregnant and the parents 
requested prenatal diagnosis. DNA isolated from the amniotic fluid sample was used as template for 
polymerase chain reaction amplification and automated sequencing. Unexpectedly, the mutation 
G2003R was also present in the fetus, suggesting that the initial occurrence was in fact not a de 
novo event. We could only explain the second occurrence of the identical mutation in this family by 
invoking the possibility of germline mosaicism. To further investigate the parental transmission of 
the mutation, we performed haplotype analysis using chromosome 3 microsatellite markers Figure 
1, synthesized based on publicly available oligonucleotide sequences (Cooperative Human Linkage 
Center and Genome Database). Polymerase chain reaction products containing microsatellite 
markers for chromosome 3 were analyzed on a 6% nondenaturing polyacrylamide gel. We 
determined that all three offspring carried the same maternal chromosome 3 haplotype. The 
clinically unaffected sister of the patient and the affected fetus shared the same paternal 
chromosome; however, the patient carried the other paternal chromosome. Thus, we concluded that 
the mutation is most likely present in a percentage of cells in the germline of the mother. 
To our knowledge, this study represents the first documented case of germline mosaicism in 
epidermolysis bullosa and serves as a reminder that germline mosaicism should be considered in 
every case when a mutation is found in the offspring but not in the parents. In the event of a de 
novo mutation, the family can be counselled that the likelihood of having another affected child is 
the same as in the general population. In the case of germline mosaicism, however, the likelihood of 
having another affected child is much higher, depending on the ratio of mutant to wild-type germ 
cells. This possibility has a significant impact on genetic counselling, and unfortunately, exact 
determination of the transmitting parent is not always possible. In the case of paternal transmission, 
a semen sample can be used for further studies to determine the percentage of mutant germ cells, 
and thus calculate an accurate risk of recurrence for the family. These findings heighten our 
awareness of the existence of unusual modes of inheritance in epidermolysis bullosa, which should 
be taken into account when counselling families about the recurrence risk for future offspring. 
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Haplotype analysis of a pedigree with DEB. The figure shows the haplotype of the family members, 
listed according to the microsatellite markers indicated on the left. The mutation G2003$ is also 
listed. The figure demonstrates that all three offspring (individuals II-1 to II-3) carry the same 
maternal (individual I-2) chromosome 3 haplotype. The two affected individuals (individuals II-2 
and II-3) display different paternal chromosome 3 haplotype. The mutation G2003 is present only in 
individuals II-2 and II-3 (gray shading), suggesting that it is only contained in a percentage of the 
maternal chromosomes. 
